{
    "clinical_study": {
        "@rank": "109254", 
        "acronym": "COMARIS", 
        "arm_group": [
            {
                "arm_group_label": "Adalimumab", 
                "arm_group_type": "Active Comparator", 
                "description": "adalimumab 40mg every 2 weeks"
            }, 
            {
                "arm_group_label": "Adalimumab + Methotrexate", 
                "arm_group_type": "Experimental", 
                "description": "adalimumab 40mg every 2 weeks and methotrexate 10mg per week"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if association of methotrexate with adalimumab\n      leads to decrease immunogenicity beside adalimumab alone in Ankylosing Spondylitis."
        }, 
        "brief_title": "Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Ankylosing Spondylitis", 
        "condition_browse": {
            "mesh_term": [
                "Spondylitis", 
                "Spondylitis, Ankylosing"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject 18 years of age or older\n\n          -  Able and willing to give written informed consent and to comply with the requirements\n             of the study protocol\n\n          -  Subject met the definition of Ankylosing Spondylitis (AS) based on ASAS Criteria\n\n          -  Subject with active AS, has had an inadequate response, an intolerance or an to one\n             or more nonsteroidal anti-inflammatory drugs\n\n        Exclusion Criteria:\n\n          -  Previous adalimumab treatment or previous treatment with more than one anti TNF alpha\n             therapy.\n\n          -  Previous methotrexate treatment, not stopped 3 month before inclusion\n\n          -  Surgery scheduled during study\n\n          -  Female subject without method of contraception\n\n          -  Contraindication to adalimumab or methotrexate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895764", 
            "org_study_id": "PHRI12-ED-COMARIS", 
            "secondary_id": [
                "2012-004939-23", 
                "A130042-32", 
                "2012-R41"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Adalimumab", 
                    "Adalimumab + Methotrexate"
                ], 
                "description": "adalimumab, subcutaneous injection, 40mg every 2 weeks, week 0 until week 26", 
                "intervention_name": "Adalimumab", 
                "intervention_type": "Drug", 
                "other_name": "Humira"
            }, 
            {
                "arm_group_label": "Adalimumab + Methotrexate", 
                "description": "methotrexate, subcutaneous injection, 10mg per week, week -2 until week 26", 
                "intervention_name": "Methotrexate", 
                "intervention_type": "Drug", 
                "other_name": "Metoject"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methotrexate", 
                "Adalimumab"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "ankylosing spondylitis", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Blois", 
                        "country": "France", 
                        "zip": "41000"
                    }, 
                    "name": "Rhumatologie, CH de BLOIS"
                }, 
                "investigator": {
                    "last_name": "Fabienne LE GUILCHARD, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }, 
                    "name": "Rhumatologie, CHRU de BREST"
                }, 
                "investigator": {
                    "last_name": "Val\u00e9rie DEVAUCHELLE, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Roche Sur Yon", 
                        "country": "France", 
                        "zip": "85925"
                    }, 
                    "name": "Rhumatologie, CHD LA ROCHE SUR YON"
                }, 
                "investigator": {
                    "last_name": "Gr\u00e9goire CORMIER, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Mans", 
                        "country": "France", 
                        "zip": "72037"
                    }, 
                    "name": "Rhumatologie, CHR du MANS"
                }, 
                "investigator": {
                    "last_name": "Emmanuelle DERNIS, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Rhumatologie, CHRU de NANTES"
                }, 
                "investigator": {
                    "last_name": "Benoit LE GOFF, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orleans", 
                        "country": "France", 
                        "zip": "45032"
                    }, 
                    "name": "Rhumatologie / IPROS, CHR d'ORLEANS"
                }, 
                "investigator": {
                    "last_name": "Carine SALLIOT, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86021"
                    }, 
                    "name": "Rhumatologie, CHRU de POITIERS"
                }, 
                "investigator": {
                    "last_name": "Elisabeth SOLAU-GERVAIS, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35203"
                    }, 
                    "name": "Rhumatologie, CHRU de RENNES"
                }, 
                "investigator": {
                    "last_name": "Aleth PERDRIGER, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Brieuc", 
                        "country": "France", 
                        "zip": "22027"
                    }, 
                    "name": "Rhumatologie, CH de SAINT BRIEUC"
                }, 
                "investigator": {
                    "last_name": "Antoine MARTIN, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Nazaire", 
                        "country": "France", 
                        "zip": "44606"
                    }, 
                    "name": "M\u00e9decine polyvalente, CH de SAINT NAZAIRE"
                }, 
                "investigator": {
                    "last_name": "Thomas ARMINGEAT, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Emilie DUCOURAU, MD"
                }, 
                "contact_backup": {
                    "last_name": "Denis MULLEMAN, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }, 
                    "name": "Rhumatologie, CHRU de TOURS"
                }, 
                "investigator": {
                    "last_name": "Denis MULLEMAN, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)", 
        "overall_contact": {
            "email": "emilie.ducourau@univ-tours.fr", 
            "last_name": "Emilie DUCOURAU, MD", 
            "phone": "02.47.47.59.17", 
            "phone_ext": "+33"
        }, 
        "overall_contact_backup": {
            "email": "yoann.desvignes@med.univ-tours.fr", 
            "last_name": "Yoann DESVIGNES", 
            "phone": "02.47.47.46.32", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "CHRU de TOURS", 
            "last_name": "Emilie DUCOURAU, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "presence or absence of antibodies against adalimumab", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895764"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline of the Ankylosing Spondylitis Disease Activity Score (ASDAS)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Change from baseline of T and B cells concentrations.", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Change from baseline of \"APRIL\" and \"TNF alpha\" concentrations", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "University Hospital, Tours", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Tours", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}